|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-12-2
|
|
pubmed:abstractText |
To evaluate the value of (18)F-FDG PET-CT for assessment of therapeutic response and prediction of patient outcome after concurrent chemoradiotherapy (CCRT) of non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
603-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21122413-Aged,
pubmed-meshheading:21122413-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21122413-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21122413-Cisplatin,
pubmed-meshheading:21122413-Combined Modality Therapy,
pubmed-meshheading:21122413-Female,
pubmed-meshheading:21122413-Fluorodeoxyglucose F18,
pubmed-meshheading:21122413-Humans,
pubmed-meshheading:21122413-Lung Neoplasms,
pubmed-meshheading:21122413-Male,
pubmed-meshheading:21122413-Middle Aged,
pubmed-meshheading:21122413-Neoplasm Staging,
pubmed-meshheading:21122413-Paclitaxel,
pubmed-meshheading:21122413-Positron-Emission Tomography,
pubmed-meshheading:21122413-Prognosis,
pubmed-meshheading:21122413-Radiopharmaceuticals,
pubmed-meshheading:21122413-Radiotherapy, Conformal,
pubmed-meshheading:21122413-Tomography, X-Ray Computed,
pubmed-meshheading:21122413-Vinblastine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
[Prognostic value of (18)F-fluorodeoxyglucose uptake in patients with non-small cell lung cancer treated by concurrent chemoradiotherapy].
|
|
pubmed:affiliation |
Department of Special Medicalcare, Shandong Cancer Hospital and Institute, Jinan, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Evaluation Studies
|
